Time-Limited Therapy with Belatacept in Kidney Transplant Recipients

Introduction: In kidney transplant recipients, belatacept is usually pursued indefinitely after it has been started. In the setting of the belatacept shortage and after having evaluated the benefit–risk ratio, we established a strategy consisting of time-limited belatacept therapy/transient calcineu...

Descripción completa

Detalles Bibliográficos
Autores principales: Letellier, Thibault, Kervella, Delphine, Sadek, Abderrahmane, Masset, Christophe, Garandeau, Claire, Fourgeux, Cynthia, Gourain, Victor, Poschmann, Jeremie, Blancho, Gilles, Ville, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181670/
https://www.ncbi.nlm.nih.gov/pubmed/35683619
http://dx.doi.org/10.3390/jcm11113229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181670/
https://www.ncbi.nlm.nih.gov/pubmed/35683619
http://dx.doi.org/10.3390/jcm11113229

Ejemplares similares